** Inovio Pharmaceuticals INO.O shares down 20.5% at $2.99 post-market as co plans equity raise
** Co, which focuses on treating HPV-related diseases, cancer, and infectious diseases, announces proposed stock and warrants offering; deal size not disclosed
** Oppenheimer and Citizens JMP jt bookrunners
** INO shares on Thurs finished session down 6.6% at $3.76, a record low close
** Plymouth Meeting, Pennsylvania-based firm has ~26.1 mln shares outstanding for ~$98 mln market cap, per LSEG
** YTD, stock has lost ~39%
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。